FDA Approves New Roche Drug Uses for Cancer, Kidney and Eye Diseases

The Oct. 8 Tecentriq decision covers a chemotherapy combination for certain stage III colon cancers; Enspryng was cleared for adults with thyroid eye disease on Oct. 15.

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TokenPost.